Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Name: Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia
Published: 2019
License: Public Domain

Institut de Recherches Internationales Servier · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

leukemia lymphoma

relapsed or refractory acute myeloid leukemia, relapsed or refractory non-hodgkin lymphoma, relapsed or refractory multiple myeloma, relapsed or refractory chronic lymphocytic leukemia, leukemia, lymphoma, myeloma, dose-escalation, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Related documents